Table 3.

Procedural Characteristics and Outcomes

Variable	Bare-Metal Stent (N=192)	Drug-Eluting Stent (N=203)	P Value
Primary indication for revascularization
Asymptomatic coronary artery disease	11 (5.7%)	13 (6.4%)	0.78
Stable angina pectoris	40 (20.8%)	45 (22.2%)	0.75
Unstable angina pectoris	100 (52.1%)	93 (45.8%)	0.21
Acute myocardial infarction	37 (19.3%)	43 (21.2%)	0.64
Cardiogenic shock on presentation	1 (0.5%)	2 (1.0%)	0.60
Glycoprotein IIb/IIIa inhibitors used	78 (40.6%)	57 (28.1%)	0.009
Distal protection device used	35 (18.3%)	66 (32.5%)	0.001
Number of lesions attempted			0.27
1	120 (62.5%)	138 (68.0%)
2	57 (29.7%)	46 (22.7%)
≥3	15 (7.8%)	19 (9.4%)
Attempted stent location			0.72
Graft only	163 (84.9%)	175 (86.2%)
Graft + 1 native vessel	24 (12.5%)	21 (10.3%)
Graft + 2 native vessels	5 (2.6%)	7 (3.4%)
In-hospital outcomes
Myocardial infarction	11 (5.7%)	4 (2.0%)	0.05
Coronary bypass surgery	0 (0%)	0 (0%)	1.00
Stroke	0 (0%)	1 (0.5%)	0.33
Death	3 (1.6%)	1 (0.5%)	0.29
Death or Q-wave MI	3 (1.6%)	2 (1.0%)	0.61
Death or MI	14 (7.3%)	5 (2.5%)	0.03
Procedural Success*	189 (98.4%)	200 (98.5%)	0.95

^*Procedural Success is defined as partial or total angiographic success, without Q-wave myocardial infarction, emergency CABG, or death.